Q2 2019 Onconova Therapeutics Inc Earnings Call Transcript
Good morning and welcome to Onconova Therapeutics Corporate Update and Second Quarter 2019 Financial Results Conference Call. At this time, I would like to turn the call over to Avi Oler, Vice President of Corporate Development and General Counsel.
Thank you, operator. Good morning, everybody, and welcome to Onconova's Second Quarter 2019 Corporate Update and Financial Results Conference Call. Earlier this morning, we issued a press release with second quarter 2019 financial results and business updates. If you have not seen this morning's press release, it is available on the Investor Relations page of our website at www.onconova.com.
On today's call, Dr. Steven Fruchtman, President and CEO, will discuss the company's recent highlights and anticipated clinical and business progress. After Steve completed his opening remarks, Mark Guerin, our Chief Financial Officer, will review second quarter
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |